Cas:106-59-2 piperazine-1,4-diamine manufacturer & supplier

We serve Chemical Name:piperazine-1,4-diamine CAS:106-59-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

piperazine-1,4-diamine

Chemical Name:piperazine-1,4-diamine
CAS.NO:106-59-2
Synonyms:N,N’-Diaminopiperazine;Piperazin-1,4-diyldiamin;1,4-Piperazinediamine;Piperazine,4-diamino;EINECS 203-413-6;1,4-diamino-piperazine
Molecular Formula:C4H12N4
Molecular Weight:116.16500
HS Code:2933599090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:192.5ºC at 760mmHg
Density:1.119g/cm3
Index of Refraction:1.542
PSA:58.52000
Exact Mass:116.10600
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like N,N’-Diaminopiperazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,4-diamino-piperazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Piperazin-1,4-diyldiamin Use and application,N,N’-Diaminopiperazine technical grade,usp/ep/jp grade.


Related News: The complete chemical and pharmaceutical industry chain consists of basic chemical raw materials, pharmaceutical intermediates, chemical raw materials and chemical preparations. piperazine-1,4-diamine manufacturer Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs. piperazine-1,4-diamine supplier Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs. piperazine-1,4-diamine vendor Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs. piperazine-1,4-diamine factory Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.